Earlier evidence for retatrutide comes from a Phase 2 trial in NEJM in 2023, which reported 24.2% weight loss at 12 mg over 48 weeks
Bariatric surgery produces results a gelatin drink never can
Knowing theyre common, often harmless, and widely shared can make them feel less alarming
Before use, the solution in the ampoule should be carefully examined for any signs of discoloration or cloudiness, and questionable solutions should be discarded
A physician-built primer on the science, the timeline, the whole-body benefits, and how we support you beyond the scale
From access to health coaching and nutrition guidance, to ongoing provider support and community connection, the infrastructure surrounding microdosing therapy ensures you have comprehensive tools to support your wellness journey